China’s largest pharmaceutical company, Jiangsu Hengrui Pharmaceuticals, is seeking to raise up to $1.3 billion through an initial public offering (IPO) on the Hong Kong Stock Exchange. Renowned law firms Cleary Gottlieb Steen & Hamilton and Commerce & Finance Law Offices are advising Jiangsu Hengrui on this significant listing. The underwriters for this IPO are represented by Herbert Smith Freehills and Jingtian & Gongcheng. Jiangsu Hengrui is already listed in Shanghai, and this Hong Kong IPO marks its first foray into this market.
For further details on the matter, the article is available to read here (note that access may be restricted by a paywall).